Skip to main content

Table 2 Histopathological characteristics

From: MDM2 gene SNP309 T/G and p53gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European Caucasians

number (%) Histopathological diagnosis (REAL-classification)
284 91.32 B-cell lymphomas
205 65.92 Diffuse large B-cell lymphoma
13 4,18 DLBCL, NOS
8 2.57 anaplastic large-cell (ALC)
46 14.79 centroblastic diffuse, NOS
16 5.14 centroblastic diffuse, NOS -> monomorphic
9 2.89 centroblastic diffuse, NOS -> multi-lobulated
89 28.62 centroblastic diffuse, NOS -> polymorphic
17 5.47 immunoblastic
4 1.29 primary mediastinal B-cell lymphoma
3 0.96 T-cell rich B-cell-lymphoma
79 25.40 Non-DLBCL B-cell lymphomas
15 4.82 centroblastic-follicular
6 1.93 centroblastic follicular and diffuse
4 1.29 mantle-cell blastic variant
3 0.96 Burkitt-lymphoma
12 3.86 high-grade Burkitt-like
5 1.61 blastic marginal-zone
16 5.14 not otherwise specified
18 5.79 unclassified (technical reasons)
27 8.68 T-cell lymphomas
20 6.43 anaplastic large-cell
4 1.29 peripheral NOS -> small and large-cell
1 0.32 T-cell-lymphoma (AILD)
2 0.64 not otherwise specified